{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:21:41Z","timestamp":1762867301513},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Incyte"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12955-017-0813-7","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T12:57:54Z","timestamp":1512565074000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Psychometric properties of morning joint stiffness duration and severity measures in patients with moderately to severely active rheumatoid arthritis"],"prefix":"10.1186","volume":"15","author":[{"given":"Elizabeth D.","family":"Bacci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy M.","family":"DeLozier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Yen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol L.","family":"Gaich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence","family":"Rooney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen W.","family":"Wyrwich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,6]]},"reference":[{"key":"813_CR1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/art.22368","volume":"56","author":"RH Straub","year":"2007","unstructured":"Straub RH, Cutolo M. Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. Arthritis Rheum. 2007;56:399\u2013408.","journal-title":"Arthritis Rheum"},{"key":"813_CR2","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1196\/annals.1361.079","volume":"1051","author":"M Cutolo","year":"2005","unstructured":"Cutolo M, Otsa K, Aakre O, Sulli A. Nocturnal hormones and clinical rhythms in rheumatoid arthritis. Ann N Y Acad Sci. 2005;1051:372\u201381.","journal-title":"Ann N Y Acad Sci"},{"key":"813_CR3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/ar4146","volume":"15","author":"JE Gibbs","year":"2013","unstructured":"Gibbs JE, Ray DW. The role of the circadian clock in rheumatoid arthritis. Arthritis Res Ther. 2013;15:205.","journal-title":"Arthritis Res Ther"},{"key":"813_CR4","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/rheumatology\/ken137","volume":"47","author":"G Westhoff","year":"2008","unstructured":"Westhoff G, Buttgereit F, Gromnica-Ihle E, Zink A. Morning stiffness and its influence on early retirement in patients with recent onset rheumatoid arthritis. Rheumatology (Oxford). 2008;47:980\u20134.","journal-title":"Rheumatology (Oxford)"},{"key":"813_CR5","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s00296-014-3040-0","volume":"34","author":"K Mattila","year":"2014","unstructured":"Mattila K, Buttgereit F, Tuominen R. Impact of morning stiffness on working behaviour and performance in people with rheumatoid arthritis. Rheumatol Int. 2014;34:1751\u20138.","journal-title":"Rheumatol Int"},{"key":"813_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/03009742.2011.566433","volume":"125","author":"S Sierakowski","year":"2011","unstructured":"Sierakowski S, Cutolo M. Morning symptoms in rheumatoid arthritis: a defining characteristic and marker of active disease. Scand J Rheumatol Suppl. 2011;125:1\u20135.","journal-title":"Scand J Rheumatol Suppl"},{"key":"813_CR7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/03009742.2011.566437","volume":"125","author":"T Sokka","year":"2011","unstructured":"Sokka T. Morning stiffness and other patient-reported outcomes of rheumatoid arthritis in clinical practice. Scand J Rheumatol Suppl. 2011;125:23\u20137.","journal-title":"Scand J Rheumatol Suppl"},{"key":"813_CR8","volume-title":"Content validity evaluation of a new diary developed to evaluate symptoms important to patients with moderate-to-severe rheumatoid arthritis","author":"AM DeLozier","year":"2015","unstructured":"DeLozier AM, Gaich CL, Vernon MK, von Maltzahn R. Content validity evaluation of a new diary developed to evaluate symptoms important to patients with moderate-to-severe rheumatoid arthritis. Philadelphia: ISPOR 20th Annual International Meeting; May 16\u201320; 2015."},{"key":"813_CR9","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1056\/NEJMoa1608345","volume":"376","author":"PC Taylor","year":"2017","unstructured":"Taylor PC, Keystone EC, van der Heijde D, Weinblatt ME, Del Carmen ML, Reyes Gonzaga J, Yakushin S, Ishii T, Emoto K, Beattie S, et al. Baricitinib versus placebo or Adalimumab in rheumatoid arthritis. N Engl J Med. 2017;376:652\u201362.","journal-title":"N Engl J Med"},{"key":"813_CR10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/annrheumdis-2016-210094","volume":"76","author":"M Dougados","year":"2017","unstructured":"Dougados M, van der Heijde D, Chen YC, Greenwald M, Drescher E, Liu J, Beattie S, Witt S, de la Torre I, Gaich C, et al. Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study. Ann Rheum Dis. 2017;76:88\u201395.","journal-title":"Ann Rheum Dis"},{"key":"813_CR11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473\u201383.","journal-title":"Med Care"},{"key":"813_CR12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00005650-199401000-00004","volume":"32","author":"CA McHorney","year":"1994","unstructured":"McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994;32:40\u201366.","journal-title":"Med Care"},{"key":"813_CR13","volume-title":"SF-36 health survey annotated bibliography: second edition (1988\u20131996)","author":"C Tsai","year":"1997","unstructured":"Tsai C, Bayliss MS, Ware JE. SF-36 health survey annotated bibliography: second edition (1988\u20131996). Boston: Health Assessment Lab, New England Medical Center; 1997."},{"key":"813_CR14","first-page":"789","volume":"9","author":"JF Fries","year":"1982","unstructured":"Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol. 1982;9:789\u201393.","journal-title":"J Rheumatol"},{"key":"813_CR15","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/rheumatology\/keu386","volume":"54","author":"N Cuperus","year":"2015","unstructured":"Cuperus N, Mahler EA, Vliet Vlieland TP, Hoogeboom TJ, van den Ende CH. Measurement properties of the health assessment questionnaire disability index for generalized osteoarthritis. Rheumatology (Oxford). 2015;54:821\u20136.","journal-title":"Rheumatology (Oxford)"},{"key":"813_CR16","volume-title":"Diagnostic and statistical manual of mental disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV). 4th ed. Washington: American Psychiatric Association; 1994.","edition":"4"},{"key":"813_CR17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","volume":"54","author":"AJ Rush","year":"2003","unstructured":"Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, et al. The 16-item quick inventory of depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54:573\u201383.","journal-title":"Biol Psychiatry"},{"key":"813_CR18","first-page":"S100","volume":"23","author":"D Aletaha","year":"2005","unstructured":"Aletaha D, Smolen J. The simplified disease activity index (SDAI) and the clinical disease activity index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol. 2005;23:S100\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"813_CR19","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/ard.2011.149765","volume":"70","author":"DT Felson","year":"2011","unstructured":"Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, Aletaha D, Allaart CF, Bathon J, Bombardieri S, et al. American College of Rheumatology\/European league against rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis. 2011;70:404\u201313.","journal-title":"Ann Rheum Dis"},{"key":"813_CR20","doi-asserted-by":"crossref","first-page":"S214","DOI":"10.1002\/art.11407","volume":"49","author":"J Fransen","year":"2003","unstructured":"Fransen J, Stucki G, van Riel PLCM. Rheumatoid arthritis measures: disease activity score (DAS), disease activity Score-28 (DAS28), rapid assessment of disease activity in rheumatology (RADAR), and rheumatoid arthritis disease activity index (RADAI). Arthritis Care Res. 2003;49:S214\u201324.","journal-title":"Arthritis Care Res"},{"key":"813_CR21","first-page":"102","volume":"86","author":"LJ DeLoach","year":"1998","unstructured":"DeLoach LJ, Higgins MS, Caplan AB, Stiff JL. The visual analog scale in the immediate postoperative period: intrasubject variability and correlation with a numeric scale. Anesth Analg. 1998;86:102\u20136.","journal-title":"Anesth Analg"},{"key":"813_CR22","volume-title":"Psychometric theory","author":"JC Nunnally","year":"1994","unstructured":"Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed. New York: McGraw-Hill; 1994.","edition":"3"},{"key":"813_CR23","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Lawrence Erlbaum Associates; 1988.","edition":"2"},{"key":"813_CR24","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/(SICI)1097-0258(19980815\/30)17:15\/16<1863::AID-SIM989>3.0.CO;2-M","volume":"17","author":"GG Koch","year":"1998","unstructured":"Koch GG, Tangen CM, Jung JW, Amara IA. Issues for covariance analysis of dichotomous and ordered categorical data from randomized clinical trials and non-parametric strategies for addressing them. Stat Med. 1998;17:1863\u201392.","journal-title":"Stat Med"},{"key":"813_CR25","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/ard.43.5.686","volume":"43","author":"JR Kirwan","year":"1984","unstructured":"Kirwan JR, Chaput de Saintonge DM, Joyce CR, Currey HL. Clinical judgment in rheumatoid arthritis. III. British rheumatologists\u2019 judgments of \u2018change in response to therapy\u2019. Ann Rheum Dis. 1984;43:686\u201394.","journal-title":"Ann Rheum Dis"},{"key":"813_CR26","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/art.1780360601","volume":"36","author":"DT Felson","year":"1993","unstructured":"Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, Furst D, Goldsmith C, Kieszak S, Lightfoot R, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The committee on outcome measures in rheumatoid arthritis clinical trials. Arthritis Rheum. 1993;36:729\u201340.","journal-title":"Arthritis Rheum"},{"key":"813_CR27","first-page":"1243","volume":"33","author":"M Soubrier","year":"2006","unstructured":"Soubrier M, Zerkak D, Gossec L, Ayral X, Roux C, Dougados M. Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice? J Rheumatol. 2006;33:1243\u20136.","journal-title":"J Rheumatol"},{"key":"813_CR28","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/acr.22592","volume":"67","author":"M Boers","year":"2015","unstructured":"Boers M, Buttgereit F, Saag K, Alten R, Grahn A, Storey D, Rice P, Kirwan J. What is the relationship between morning symptoms and measures of disease activity in patents with rheumatoid arthritis. Arthrit Care Res. 2015;67:1202\u20139.","journal-title":"Arthrit Care Res"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-017-0813-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T12:58:03Z","timestamp":1512565083000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-017-0813-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["813"],"URL":"https:\/\/doi.org\/10.1186\/s12955-017-0813-7","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"239"}}